WORCESTER, Mass., Sept. 18, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will be making a podium presentation at the 43rd Annual Meeting of the European Society Association for the Study of Diabetes (EASD) in Amsterdam, The Netherlands, September 17 - 21, 2007 (http://www.easd.org).
